Ibd Blood Data Bank Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Ibd Blood Data Bank Foundation
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Chandak, Rajeshkumar Maheshwari, Lakshit Tawari, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300GJ2021NPL125909
- Company No.
125909
- Company Classification
Private Not For Profit Company
- Incorporation Date
28 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ibd Blood Data Bank Foundation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar Maheshwari  | Director | 28-Sep-2021 | Current |
| Shailesh Chandak | Director | 28-Sep-2021 | Current |
| Lakshit Tawari | Director | 28-Sep-2021 | Current |
| Dinesh Rathi | Director | 28-Sep-2021 | Current |
Financial Performance of Ibd Blood Data Bank Foundation.
Ibd Blood Data Bank Foundation, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ibd Blood Data Bank Foundation?
Unlock access to Ibd Blood Data Bank Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innovative Pillars Private LimitedActive 12 years 7 monthsRajeshkumar Maheshwari is a mutual person
- World Screen Rescue Private LimitedActive 6 years 2 months
Rajeshkumar Maheshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibd Blood Data Bank Foundation?
Ibd Blood Data Bank Foundation has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibd Blood Data Bank Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibd Blood Data Bank Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
